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Abstract 
 
In this work, the photophysical properties of the fluorescent anticoagulant 
drug warfarin (W) were examined in water and inside methyl-β-cyclodextrins (Me-β-
CD) through absorption and time-resolved fluorescence measurements at pH 3 and 9 
and upon the selective excitation of different isomers of warfarin at 280 and 320 nm. 
The values of binding constants (2.9 × 103 M–1 and 4.2 × 102 M–1 for protonated and 
deprotonated forms, respectively) were extracted from the spectrophotometric data. 
Both absorption and time-resolved fluorescence results established that the interior of 
the macromolecular host binds preferentially the open protonated form, red shifts the 
maximum of its absorption of light at ~305 nm, extends its excited-state lifetime, and 
decreases its emission quantum yield (ՓF). Collectively, sequestration of the open 
guest molecules decreases markedly their radiative rate constants (kr), likely due to 
formation of hydrogen-bonded complexes in both the ground and excited states. Due 
to lack of interactions, no change was observed in the excited-state lifetime of the 
cyclic form in the presence of Me-β-CD. The host also increases the excited-state 
lifetime and ՓF of the drug deprotonated form (W-). These later findings could be 
attributed to the increased rigidity inside the cavity of Me-β-CD. The pKa values 
extracted from the variations of the UV-visible absorption spectra of W versus the 
pH of aqueous solution showed that the open isomer is more acidic in both ground 
and excited states. The positive shifts in pKa values induced by three derivatives of 
cyclodextrins: HE-β-CD, Ac-β-CD, and Me-β-CD supported the preferential binding 
of these hosts to open isomers over cyclic. 
 
Keywords: open-cyclic tautomers, molecular switching, decay-associated spectra, 
warfarin, excited-state lifetime, cyclodextrins. 
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في خاصية الانفتاح والانغلاق على  سيكلودكسترينتأثير تكوين معقدات داخل أوعية ال
 دواء الوارفارين
 صالملخ
في هذا العمل ، تم فحص الخواص الفيزيائية الضوئية لعقار الوارفارين المضاد للتجلط 
) من خلال DC-β-eMسيكلودكسترين (-ميثيللل الجزيئيةالأوعية  في الماء وداخل  لدمويا
يزومرات مختلفة من باالخاصة  9و  3عند الرقم الهيدروجيني  ثوالانبعا الامتصاصقياسات 
 ) 1-متر 012×  2.4و   1-متر 013×  9.2( معاملات الارتباط الوارفارين. تم استخلاص 
أن والانبعاثات الحركية . أثبتت كل من نتائج الامتصاص عقارحمضية وقاعدية مختلفة لللأشكال 
امتصاص العقار مسببا المفتوح ،  حمضيالشكل الب يفضل الارتباطمضيف الالجزء الداخلي من 
 نسبةيقلل من كما لحالة المثارة ، ل الزمنيعمرال ةلاطإ~ نانومتر ، و 503عند أقل  ضوئيةلطاقة 
 ذو خاصية الانفتاح بالشكل جزيئات الضيفبواسطة  رتباطالان إ عام. وبشكل (ՓF) الانبعاث
 روابط، ويرجع ذلك إلى تكوين للدواء) krشعاع (الإ معاملاتقلل بشكل ملحوظ من ت
 المثارة.  ة المستقرة وفي كل من الحال يةهيدروجين
 أوعية ،التحول الجزيئي، الأطياف الحركية، زمن الحالة المثارة: مفاهيم البحث الرئيسية
  .وارفارين ،سيكلودكسترينال
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Chapter 1: Introduction 
 
1.1 Relevant Literature 
1.1.1 Supramolecular Chemistry as a Science 
Since its first development in 1987 by Lehn, Cram and Pedesen [1]. 
supramolecular chemistry has been expanding into various applications, including 
biomedical applications [2], [3]. The host-guest concept involves non-covalent 
interaction of a guest (G) molecule inside the cavity of a host (H) molecule (Figure 
1). These interactions include hydrogen-bonding interaction, π−π stacking 
interaction, electrostatic interaction, van der Waals force, and 
hydrophobic/hydrophilic attraction [4]. 
 
 
 
 
 
 
 
 
 
 
Figure 1: Self-assembly (a), self-sorting (b) and stimuli-responsiveness of 
supramolecular systems (c) 
 
Figure 1 illustrates two important features of those non-covalent interactions: 
reversibility and responsiveness to external stimuli, such as pH, light, electrical 
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signal, heat, chemical competitor, etc. While self-assembly process (Figure 1a) 
describes transformation of small building blocks into one defined aggregate under 
certain conditions, self-sorting (Figure 1b) process is simultaneous occurrence of 
multiple self-assemblies into multiple well-defined aggregates under similar 
conditions. If building blocks of those self-assembling or self-sorting systems re-
configured in responding to certain stimuli, the systems said to be stimuli-responsive 
systems (Figure 1c).  
Supramolecular materials are naturally composed of two or more components 
that intrinsically self-assembled by non-covalent interactions. Such weak interactions 
inherently endow the materials with reversible, spontaneous assembly or disassembly 
feature, allowing convenient dissociation and reconstruction of the supramolecular 
systems at a low energy cost. Consequently, the “bottom-up” supramolecular 
approach has an adaptive capability in response to external stimuli that can trigger 
the self-assembly/disassembly equilibrium at the molecular level, leading into the 
design and fabrication of stimuli-responsive functional, smart materials  for various 
applications, such as in biomedicine [5]. 
When compared to routine covalent modifications, the non-covalent method 
considered inexpensive and environmentally safe approach. On the one hand, it 
bypasses the burdens in multiple organic synthesis steps [6], and on the other it may 
combine already existing products in the market, whose safety and low-toxicity have 
been already confirmed [7], [8]. The low toxicity, in particular, motivated more 
researchers to utilize supramolecular systems in biological field as bio-inspired 
materials [9], [10]. 
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1.1.2 Types of Molecular Containers (Hosts) 
There have been several host-guest systems reported in aqueous solution for 
biomedical applications with stimuli-responsive abilities [11]. Cyclodextrins (CDs) 
[12] and Cucurbit[n]uril (CBs) [13] are examples of hosts that bind with the guest by 
noncovalent interactions as illustrated in Figure 2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Chemical structures of various derivatives of cyclodextrins (CDs) and 
cucurbiturils (CBs) molecular containers 
HE-β-CD 
Ac-β-CD 
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Table 1 summarizes some features that distinguish the two type of containers 
CDs and CBs. For example, CBs have much higher affinity to bind guest molecules 
[2]. For instance, the binding constant (K) for CDs-based host−guest complexes can 
reach 104 M−1 [12], [14], [15], and that for CBs-based host−guest complexes can be 
as high as 1015 M−1 [16]. Another important feature is the distinct carbonyl group, 
which is responsible for the binding between CBs and cationic guests through ion-
dipole interactions, leading to an increase in their acid-dissociation constant [17].  
However the important feature of CDs is their ability to increase the 
solubility of poorly soluble drugs [12], [14], [15]. CDs consist of (α-1,4-)-linked α-
D-glucopyranose units with a hydrophobic central cavity which gives CDs the cones 
shape with the hydrophilic outer surface [12], [14], [15].  There are three main types 
of CDs (α, β and γ), the difference between them is the number of glucopyranose 
units in their structures which is six, seven and eight, respectively [12], [14], [15].  
On the other hand, CBs composed of glycoluril units connected by methylene 
groups. The isolation of major CBs members was achieved only 80 years after its 
first synthesis in acidic media. By the year 2000, all members of CBs from 1-10 were 
isolated except CB9 (i.e., CB5, CB6, CB7, CB8, and CB10) [18]–[20]. In 2015, 
CB14 was isolated [21]. 
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Table 1: Major differences between CBs and CDs molecular containers 
 
1.1.3 pKa of other drugs inside CBs and CDs 
In general, inclusion of guest molecules inside CDs and CBs changes their 
physical and chemical properties. Also, CDs prefer to bind the neutral forms of 
guests over their cationic forms, consequently, this will induce negative pKa shift of 
guest molecules[2], [22]–[24]. On the other hand, CBs will induce positive pKa shift 
of guest molecules because it favors binding the protonated form rather than the 
neutral form [25]–[27]. The host-induced pKa shift was related to the carbonyl 
groups of CBs that are partially negatively charged [2], [25], [28]–[31]. 
For example, Saleh et al. studied the encapsulation of benzimidazoles [26], 
[32] which are commercial fungicides [33], [34] with CB7. The inclusion affects the 
pKa of the benzimidazoles and leads to positive pKa shift. This is equivalent to say 
that, CB7 has stabilized the protonated form of benzimidazole guest molecule, 
 CBs CDs 
Binding constant 10
15 M−1 104 M−1 
Features carbonyl group and 
ion-dipole interactions 
)of guests aKincrease p( 
increase the solubility of 
insoluble guests 
Structure composed of glycoluril units 
connected by methylene 
groups with a hydrophobic 
cavity 
Composed of glucopyranose 
units with a hydrophobic 
cavity 
Types CB5, CB6, CB7, CB8, CB10, 
and CB14 
α, β and γ and derivatives 
thereof 
6 
 
 
 
 
increasing its solubility [26]. In another example, the interaction of CB7 with 
tropicamide which is an ocular drug; whose pKa is 5.4 was also examined [35], [36]. 
Encapsulation of tropicamide with CB7 and CB8 increases the pKa by (0.5 and 1.5) 
units respectively. As a result, the ionization degree of the drug was enhanced, which 
is of relevant to drug bioavailability [35]. 
From a different prospective, inclusion of drugs inside CDs and CBs has not 
only induced pKa shift but also increased the fluorescence of these drugs [31], [35]. 
Koner et al. studied the encapsulation of dapoxyl sodium sulfonate (DSS) with α- 
and β-cyclodextrins. Not only a 0.8 negative pKa shift was noticed due to 
encapsulation of DSS inside β-cyclodextrins, but also the emission of the DSS was 
consequently  increased significantly [37]. 
1.1.4 Biochemistry of Warfarin and its Importance  
Warfarin is an oral anticoagulant drug that is widely used for a patient who has 
cardiovascular disease [38]. The mechanism of how warfarin prevents blood from 
clotting is shown in Figure 3 [39], which illustrates Vitamin K cycle. Warfarin 
reduces the production of clotting factors II, VII, IX and X, and the anticoagulant 
proteins C and S. This could happen by inhibiting the enzyme, Vitamin K epoxide 
reductase, that is required to reproduce vitamin K epoxide in the reduced form. 
Reduced vitamin K1 (vitamin K1H2) is required as cofactor for γ-carboxylase to 
converts glutamic acid (Glu) residues to γ-carboxyglutamic acid (Gla)  by adding 
CO2, which is needed to induce blood clotting [39]. 
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1.1.5 Warfarin as Fluorescent Probe 
The fluorescence properties of warfarin which is a coumarin derivative [40] 
have attracted attention for several decades. Like other fluorescent probes, coumarins 
display photophysical properties that are sensitive to their local environments, such 
as supramolecular host cavities [41]. Within this context, supramolecular host-guest 
approach alongside fluorescence behavior of new coumarin derivative was exploited 
by Saleh et al. towards molecular recognition of optically inactive analytes [42].  
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Figure 3: Vitamin K cycle  
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There have been number of studies on the structures of W in different 
solvents and at different pH by NMR, absorption and time-resolved fluorescence 
[43]–[46]. The early precedent reports described structures of drug in solution [43], 
[44] to be present at pH lower than its pKa ~ 5 as either open or cyclic protonated 
form and at pH higher than its pKa as deprotonated form, whose side chain is open. 
In addition to that, photophysical properties of W in different solvents and solvent 
mixtures were profoundly examined [45], [46].  
1.1.6 Time-Resolved Fluorescence  
One of the most powerful tools for investigating the physical and chemical 
properties of matter or biological systems is the time-resolved fluorescence 
spectroscopy [47]. This becomes essential in light of the fact that steady state 
emission spectra sometimes are unspecified because the overlap emission profile of 
different fluorophores. In addition, steady-state fluorescence spectroscopy is not 
quantitative due to bleaching effects and gives no information in relation to the rate 
of deactivation process of an exited state of a drug molecule, as summarized by the 
Jablonski diagram in Figure 4 [48]. 
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1.1.6.1 Time-Correlated Single Photon Counting (TCSPC) 
One of the most popular ways of measuring time-resolved fluorescence is 
(TCSPC). The principle of this method is illustrated in Figure 5 [48]. A molecule 
will be excited by a laser pulse, a beam splitter is used to split part of the laser light 
which will reach to the photodiode. The photodiode is responsible for forming an 
electrical pulse that will be converted to ‘start’ signal by the discriminator. However, 
the stop signal is produced from the photon emitted by the sample that is recorded by 
a photomultiplier. The start signal is then required to start the time-to-amplitude 
converter (TAC).  
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Figure 4: Representative Jablonski diagram 
10 
 
 
 
 
TAC is the most important part of the TCSPC technique because of its role, 
which is measuring the difference in time between the start and stop signals that are 
proportional to the analogue voltage signal. Consequently, the voltage that produced 
by TAC is stored in a multi-channel analyzer [48]. 
 
 
 
Figure 5: Time-correlated single photon counting (TCSPC) diagram 
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1.2 Aim of This Study 
Our goal is to characterize the photophysical behaviors of warfarin (W) inside 
cyclodextrin macrocycles as shown in (Figure 6). In previous work, steady-state 
fluorescence measurements were studied. However, to understand the effect of 
encapsulation of warfarin on emission, a more quantitative tool for examining the 
effects of supramolecular cavities is needed. Accordingly, measurements of 
fluorescence lifetimes of W in presence and absence of cyclodextrins are highly 
motivated in the present work.  
 
 
 
 
 
 
 
 
Figure 6: Structural formulas of protonated warfarin (W): Keto-Enol tautomerism, 
deprotonated warfarin (W−), and methyl-β-cyclodextrins (Me-β-CD) molecular 
container 
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Chapter 2: Experimental Work  
 
2.1 Reagents 
Wafarin (W), Acetyl-β-cyclodextrins (Ac-β-CD), Methyl-β-cyclodextrins 
(Me-β-CD), and (2-Hydroxyethyl)-β-cyclodextrins (HE-β-CD) were purchased from 
Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany (purity 99 %). D2O, DCl and 
NaOD were also purchased from Sigma-Aldrich. Millipore water had conductivity 
less than 0.05 μS. The pH values of the solutions were adjusted (± 0.2 units) by 
adding adequate amounts of HCl or NaOH.  
2.2 Absorption/Steady-State Fluorescence Spectroscopy. 
The UV/Visible absorption spectra were measured on Cary-300 instrument 
(Agilent) at room temperature, between 200 and 500 nm.  Fluorescence spectra 
measurements were scanned at room temperature, between 300 and 550 nm on a 
Cary-Eclipse fluorimeter. Slit widths were 5 nm for both excitation and emission 
monochromators, unless otherwise specified. pH values were recorded using a pH 
meter (WTW 330i equipped with a WTW SenTix Mic glass electrode). Quartz 
cuvettes (1.0 cm, 3.0 mL) were used in all spectroscopic measurements and were 
obtained from Starna Cells Inc. (Atascadero, CA).  
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2.3 pH-Titration Studies 
The pH titration by UV–Visible absorption spectroscopic method was 
accomplished by measuring the pH values of about 3 ml solutions contained in a 
rectangular quartz cuvette with 1 cm optical path length, and the absorption spectra 
were then recorded. To adjust pH, microliter volumes from 0.01 and 0.1M NaOH 
solution were pipetted consecutively to achieve the indicated pH values. The pKa 
value was finally determined from fitting the titration data at a selected wavelength 
to sigmoidal formula derived from Henderson-Hasselbalch and Beer-Lambert laws. 
The fitting algorithm was provided by SigmaPlot’s software (version 6.1; SPCC, 
Inc., Chicago, Illinois, USA).  
2.4 Steady-State Binding Titration Studies 
In the titration experiment, the total concentrations of the W were kept 
constant and that of the host was gradually increased. The pH of a certain volume of 
H2O was first adjusted to either ~3 or ~9 in which a stock solution of W was 
prepared to give a final concentration of ~25 μM. A calculated weight of β-CD 
derivatives was added to the same solution of W to prepare the stock solution of the 
complex (~ 3.5 mM). The solutions with the final concentration of β-CD were 
prepared by gradually adding increment volumes of the complex’s stock solution to 
2.4 ml of the free W directly in the quartz cuvettes. The absorption or fluorescence 
spectra were measured for each solution. The signals at certain wavelength were 
plotted as a function of host’s total concentrations. The intermolecular interaction 
between β-CD and W may be quantified by the affinity constant referred to as the 
association equilibrium (K): 
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             W + β-CD  W-β-CD                                                                          (1) 
𝐾 =
[𝑊−β−CD]
[𝑊][β−CD]   
                                                                        (2) 
CW = [W] + [W-β-CD]                                                            (3) 
Cβ-CD = [β-CD] + [W-β-CD]                                                                       (4) 
Where CW and Cβ-CD mean the total concentrations of W and β-CD, respectively. It 
can be written that: 
Y (Reading at certain λ) = constant 1 * [W] + constant 2 * [W-β-CD]                    (5) 
Using Eqs.(2)-(5), we obtain  
∆Y =
Δ(constant)Cβ−CD
2
KCW−1−KCβ−CD+
√(1−KCW+KCβ−CD)
2
+4KCW
+1
                    (6) 
 
Where ΔY = optical changes at a given λ; Δ(constant)= the difference 
between the molar absortivity of free and β-CD-complexed W in the case of 
absorption titration, and K = binding constant. The binding constants (K) were then 
evaluated by using the nonlinear formula of Eq. (6). Constant 2 was left as a floating 
parameter in the analysis by Levenberg-Marquardt algorithm, which was provided by 
SigmaPlot’s software. 
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2.5 Time-Resolved Fluorescence Measurements 
The emission decays of W in absence and presence of Me-β-CD at different 
pH values were collected using LifeSpec II spectrometer that is based on TCSPC 
method with excitation at 280 and 320 nm using two Edinburgh diode lasers with 
repetition rate at 20 MHz, time resolution of 90 ps, and a red-sensitive high-speed 
PMT detector (Hamamatsu, H5773-04). Emission decay were collected every 10 nm 
over the entire emission spectra of W and W-β-CD complex in aqueous solution with 
a dwell time of 50 s at each wavelength. The data were globally fitted to mono-
exponential and bi-exponential model functions depending on the tested sample, then 
convoluted with instrument response function (IRF) of ~90 ps. The time-resolved 
data were specifically analyzed using Edinburgh FAST software (Appendix) in 
which decay-associated spectra (DAS) were constructed from the extracted intensity-
contribution fraction (fi) calculated from the pre-exponential amplitudes (Bi), as 
follows:  
𝐼(𝑡) = ∑ 𝐵𝑖𝑒𝑥𝑝(−𝑡/𝜏𝑖)𝑖                                                                     (7) 
𝑓𝑖 =
𝐵𝑖𝜏𝑖
∑ 𝐵𝑗𝜏𝑗𝑗
                                                                                                       (8) 
𝜏: 𝑙𝑖𝑓𝑒𝑡𝑖𝑚𝑒 𝑓𝑜𝑟 𝑒𝑎𝑐ℎ 𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑛𝑖𝑐 𝑠𝑡𝑎𝑡𝑒 (𝑠𝑝𝑒𝑐𝑖𝑒𝑠)                                                                                                      
        Target analysis utilizing Glotaran software11 were performed to confirm the 
kinetic expression for the population transfer of the two excited states that belong to 
free and CD-complexed W. Results indicated two mono-exponentially in parallel, 
which validates the meaning of DAS as described in text. 
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Chapter 3: Results & Discussion 
 
3.1 Preliminary Investigation  
At the beginning of this work, the establishment of reversible and stimuli-
responsiveness host-guest complexes to calcium ions in aqueous solutions was 
pursued. The reversibility in drug retention and release can be achieved in response 
to the added calcium ions to different host-guest complexes of warfarin with 
cyclodextrins. While the drug causes blood bleeding, addition of calcium would then 
replace the drug from the cavity of host, inducing blood clotting [39]. Our envisaged 
results are inspired by recent reports [26], [37] on the possibility of reversibly tune 
the binding affinity of the guest to different hosts utilizing host-induced pKa shifts 
which is accompanied by modulation of fluorescence signal.  
Collectively, our focus was on creating a balance between blood bleeding and 
blood clotting that could be utilized in blood cells in the future while being 
monitored online by emission signal. The inspiration specifically comes from the 
ability of carbonyl-containing containers (see Ac-β-CD Figure 2) to tune the pKa 
values of the embedded guests due to ion-dipole interaction. 
Unfortunately, as shown in Figures 7-10 the pKa shift is less than 1 unit 
between Warfarin and CDs. As a result, monitoring the stimuli responsiveness to 
calcium becomes impractical under these conditions. Alternatively, we opted to 
pursue the photochemistry of warfarin in water and inside CD with a similar aim 
towards establishing stimuli-responsive, reversible system yet due to the ability of 
host to induce molecular switching instead of pKa shifts. 
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Figure 7: UV-Visible absorption spectra at different pH values of W in Me-β-CD 
with Ca+2 
Figure 8: UV–Visible absorption spectra of W in aqueous solutions at different pH values 
from 2-10 in water and inside Me-β-CD. The experimental fitting error for the indicated 
pKa values and the corresponding spectra are shown in the insets 
+2 
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Figure 9: UV-Visible absorption spectra at different pH values of W in Ac-β-CD 
with Ca+2 
3) 
Figure 10: UV–Visible absorption spectra of W in aqueous solutions at different pH 
values from 2-10 in water and inside Ac-β-CD. The experimental fitting error for the 
indicated pKa values and the corresponding spectra are shown in the insets 
+2 
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3.2 Interactions of Warfarin with Cyclodextrins 
Precedent reports on the interactions of W with several derivatives of CDs 
[46], [49], [38], [50] have been considered in planning the experiments in this work. 
Figure 11 shows new derivatives of β-CD were pursed, namely Acetyl-β-CD and 2-
Hydroxyl Ethyl-β-CD. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: The structures of selected β-cyclodextrins macrocycles in the present 
work that were not studied before with W 
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3.2.1 Interactions of Warfarin with Ac-β-CD at pH 3 
The rationale behinds our selection arises from the presence of additional 
hydroxyl or carbonyl functional groups that could enhance interaction with W. 
Unfortunately, Ac-β-CD cyclodextrin at pH 3 gave weak or no interaction with W, as 
monitored by UV-Visible absorption measurements in Figure 12. 
 
Figure 12 : UV–Visible absorption titration of W (25 μM) with Ac-β-CD at pH 3; the 
inset shows the corresponding titration curve and the 1:1 binding fit (solid line) with 
K = (5.5 ± 78) M‒1. The very large error in binding affinity reflects very weak 
binding 
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3.2.2 Interactions of Warfarin with Ac-β-CD at pH 9 
In addition to that, even at pH 9 no isosbestic points was noticed as shown in 
Figure 13. Consequently, Ac-β-CD gave no interaction with warfarin at high pH. 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: UV–Visible absorption titration of W (25 μM) with Ac-β-CD at pH 9 
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3.2.3 Interactions of Warfarin with Me-β-CD at pH 3 
However, previously examined derivative Me-β-CD gave the highest binding 
constants [49]. In Figure 14 at pH 3, only the open protonated form moderately 
reacts with the host (K= 2,900 M-1) because isosbestic points were only seen at 305 
nm. Vasquez  et al. indicated that the absorption peak at 310 nm is attributed to the 
warfarin form with an open side chain, and at 280 nm it is a cyclic hemiketal [46]. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: UV–Visible absorption titration of W (25 μM) with Me-β-CD at pH 3; the 
inset shows the corresponding titration curve and the 1:1 binding fit (solid line) with 
K = (2.9 ± 0.3) × 103 M‒1 
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3.2.4 Interactions of Warfarin with Me-β-CD at pH 9 
 However W¯ weakly binds CD at high pH (Figure 15) with binding constant 
of 420 M-1 in agreement with previous reports [38], [46], [50].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Upon addition of Me-β-CD host molecules (up to 40 equivalents) to the 
aqueous solutions of W at pH 3 and 9 (Figure 14,15), characteristic changes in the 
UV–Visible absorption spectra were observed with the occurrence of several 
isosbestic points (311 nm, 315 nm, and 320 nm) confirming the formation of a 1:1 
binding stoichiometry [46].  
Figure 15: UV–Visible absorption titration of W (25 μM) with Me-β-CD at pH 9; the 
inset shows the corresponding titration curve and the 1:1 binding fit (solid line) with 
K = (4.2 ± 1.0) × 102 M‒1 
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The corresponding binding constants between W and Me-β-CD at a given pH 
were derived directly from the optical titration plot at a given wavelength using the 
formula described in the experimental section.      
Absorption spectra upon addition of β-CD to W in water at pH 7.4 (phosphate 
buffer) were measured by Vullve et al., [46] suggesting that assumption of a 1:1 ratio 
is valid for this particular molecular complex. W exists predominantly in its open 
form when bound to β-CD [43], [44]. They attributed this observation to a steric 
factor that forces W to remain in its open structure. Initially it was expected that 
hydrophobic cavity of β-CD would stabilize the cyclic form by analogy to earlier 
report in other hydrophobic media such as Cytochrome P450 2C9 (CYP2C9) [51] .  
Addition of β-CD caused less than 10% change in the absorption at 310 nm. These  
findings support the conclusion made by Vullve et al. [46] since only the longest 
wavelength absorption maxima was affected upon addition of Me-β-CD, shifting 
from 305 nm to 306 nm at pH 3.  
3.3 Optical Measurements and Host-Induced pKa Shifts 
A very recent experimental and theoretical investigations by Nowak et al. on 
several hydroxycouamrin derivatives concluded that different location of hydroxyl 
group should affect the value of pKa [52].
 Motivated by this work, the changes of 
absorption spectral profiles of W free and CD-complexes in aqueous solutions was 
graphed as a function of pH values as shown in Figures 16-19. 
  
25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: UV-Visible absorption spectra at different pH values of W in water. The 
sigmoidal fitting error for each extracted pKa at 280 (CYCLIC) and 320 nm (OPEN) 
are shown in the insets 
Figure 17: UV-Visible absorption spectra at different pH values of W in HE-β-CD. 
The sigmoidal fitting error for each extracted pKa at 280 (CYCLIC) and 320 nm 
(OPEN) are shown in the insets 
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Figure 18: UV-Visible absorption spectra at different pH values of W in Ac-β-CD 
host. The sigmoidal fitting error for each extracted pKa at 280 (CYCLIC) and 320 
nm (OPEN) are shown in the insets 
3) 
 
Figure 19: UV-Visible absorption spectra at different pH values of W in ME-β-CD. 
The sigmoidal fitting error for each extracted pKa at 280 (CYCLIC) and 320 nm 
(OPEN) are shown in the insets 
 
3) 
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Although Me-β-CD-induced pKa shifts corresponding to the deprotonation 
processes of the hydroxyl group in coumarin ring (Figure 6) have been studied before 
by Nowak et al. [49], our inspiration specifically comes from the expected 
dependence of extracted pKa values on the selected wavelength in the corresponding 
titration plots. Also, these experiments should serve fluorescence lifetime data at 
different pH and confirm the strongest interactions with methylated CDs.  
Figures 20-21 illustrated the pH titration plots for the cyclic and open forms. 
Positive shifts in pKa  were observed upon addition of all CD derivatives in aqueous 
solution under similar conditions of ionic strength effects [53]. Regardless of the type 
of isomer, Me-β-CD-assisted pKa shifts are always larger than those induced by Ac-
β-CD (ΔpKa ~ 0.9 vs. ~ 0.7 for open forms and ~ 0.6 vs. ~ 0.3 for cyclic forms). The 
HE-β-CD induced the least pKa shifts (ΔpKa ~ 0.4 for open forms, and no shift 
observed in case of cyclic forms). 
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Figure 21: UV–Visible absorption spectra of W in aqueous solutions at different pH 
values from 2-10 λabs = 305 in water and inside HE-β-CD, Ac-β-CD, and Me-β-CD. 
The experimental fitting error for the indicated pKa values and the corresponding 
spectra are shown in Figure 16-19 
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Figure 20: UV–Visible absorption spectra of W in aqueous solutions at different pH 
values from 2-10 at λabs = 280 nm in water and inside HE-β-CD, Ac-β-CD, and Me-
β-CD. The experimental fitting error for the indicated pKa values and the 
corresponding spectra are shown in Figures 16-19 
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The host-induced pKa shifts reflect the changes in the binding affinities of drug to 
β-CD derivatives in the ground states (see Me-β-CD as an example at pH 3 and 9 in 
Figures 14-15), thus rationalized by the preferential interactions of host towards the 
protonated form over the deprotonated one [54]. Nowak et al.,[49] attributed the 
strongest pKa shifts in Me-β-CD to the presence of methyl group that may have 
preferentially interacted with the CD cavity.  
More important to the focus of this work is the observation that upon 
inclusion in any of the three β-CD hosts, the increase in pKa of the open isomer was 
more pronounced than that of cyclic one, supporting the selective interaction with 
open form over the cyclic one.  
In addition to that, open form of free W appears to be more acidic in ground 
state (pKa 5.1 vs. 5.3) than the cylclic one, presumably due to extending electron 
delocalization in the final charged product (W¯) in the former case [52]. 
3.4 Excitation, pH and Cyclodextrin Dependence of Warfarin Steady-State 
Fluorescence 
This work specifically aimed at investigating the dependence of fluorescence 
of W on pH and excitation wavelength in the absence and presence of Me-β-CD, the 
host which has sufficiently interacted with W by virtue of the above absorption 
measurements. Fluorescence pH titration experiment was conducted as illustrated in 
Figures 22-23. Different pKa values were extracted upon exciting W in water at 280 
nm and 320 nm (pKa 6.1 vs. 5.7), which is again attributed to the deprotonation of the 
hydroxyl proton (Figure 6) with the open form being more acidic. 
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Figure 23: Fluorescence spectra of W (25 μM) at different pH values with excitation at 
280 nm; the inset shows the experimental fit to a sigmoidal function (solid line), which 
gives pKa = 6.14 ± 0.05. Slit widths were 5 nm for excitation and 10 nm for emission 
Figure 22: Fluorescence spectra of W (25 μM) at different pH values with excitation 
at 320 nm ; the inset shows the experimental fit to a sigmoidal function (solid line), 
which gives pKa = 5.70 ± 0.07. Slit widths were 5 nm for excitation and emission 
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This could be ascribed to extended electron delocalization in the excited-state 
structure of the formed deprotonated form in parallel to the behaviors of isomers in 
the ground-state [53].  It must be noted that open and cyclic forms, despite having 
similar emission peaks, gave different emission profile when excited at 280 nm and 
320 nm as illustrated in Figure 24, confirming the persistence of intramolecular 
proton transfer from the open form to cyclic tautomer (Figure 6) in the excited state.  
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Figure 24: Fluorescence spectra of W (25 µM) at pH 2.5 and 10 with λex = 320 nm 
and λex = 280 nm as labeled by a distinct color. While no change in peak position, 
spectra of neutral W excited at 280 nm (dark yellow) and 320 nm (dark green) are 
different 
32 
 
 
 
 
 
As far as the effects of CDs on emission of W, contrarily to the observed 
three-fold fluorescence enhancement upon inclusion of W¯ form at pH 9 (Figure 25; 
excitation at 320 nm) with binding affinity of 266 M-1 in agreement previous reports 
[38], [46], [50], the protonated (open or cyclic) forms at pH 3 showed very weak 
enhancement in fluorescence upon addition of 10 equivalents of host as illustrated in 
Figures 26-27. These contradictable results warrant further investigations using time-
resolved fluorescence spectroscopy.  
Figure 25: Fluorescence titration of W (25 μM) with Me-β-CD at pH 9 with 
excitation at 320 nm the inset shows the corresponding titration curve and the 1:1 
binding fit (solid line) with K = (2.66 ± 0.06) × 102 M‒1 
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Figure 26: Fluorescence spectra of W (25 µM) at pH 3 upon the addition of Me-β-
CD up to 250 µM (10 equiv.) with λex = 320 nm, no significant changes in spectra 
were observed 
 
Wavelength / nm
350 400 450 500 550 600
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
0
50
100
150
200
250
300

ex
 = 320 nm, pH 3
W, OPEN
358
358
W-Me--CD
W
A 
Figure 27: Fluorescence spectra of W (25 µM) at pH 3 upon the addition of Me-β-
CD up to 250 µM (10 equiv.) with λex = 280 nm, no significant changes in spectra 
were observed 
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3.5 Fluorescence Lifetime Measurements/Decay-Associated Spectra (DAS) 
Time-resolved fluorescence measurements of W at pH 3 and 9 in absence and 
presence of Me-β-CD was opted to rationalize the no enhancement in fluorescence of 
protonated W upon inclusion compared to those results observed at pH 9. Also 
sought to separate the sequestering effects of CD on each protonated isomer (open 
vs. cyclic), by monitoring the change in excited-state lifetime when selectively 
exciting W at 320 nm and 280 nm, respectively.  
Previously, the two forms were simultaneously excited at 300 nm [45]. 
Emission decays collected every 10 nm across the entire emission spectra of free W 
at pH 3 upon excitation at 320 nm and 280 were globally fitted to monoexponential 
decays as shown in Figures 32-33 (Appendix) and tabulated in Table 2. 
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Table 2: Spectroscopic and photophysical data of W at 25 µM in absence and in 
presence of Me-β-CD (1.0 mM). The DAS maximum for each lifetime is given in 
bracket 
a Upon excitation at 280 nm, no change in excited-state lifetime was observed upon inclusion           
at pH 3. b Values are presented as mean ± standard deviation. The estimated experimental 
error was 20% and 1.6% for the complex lifetimes at pH 3 and 9, respectively. 
 
The excited-state lifetimes appear within our instrument resolution of 90 ps in 
agreement with others [45]. However, when Me-β-CD complex were excited at pH 3 
both mono-exponential and biexponential decays were observed as shown in Figures 
34-35 (Appendix).  
Although addition of CD at pH 3 did not affect the position of peaks (390 
nm), excited-state lifetime increased but only when the complex was excited at 320 
nm, and not 280 nm (Figure 28, 34 and 35), supporting that Me-β-CD host favors the 
open tautomer form. Even though emission decays of drugs were collected in Figures 
28-29 upon addition of 40 equivalents of host (as limited by its solubility in water of 
about 15 mM), complete formation of complex has not been achieved due to 
relatively weak binding constant.  
Drug Forms 
 
λabs  / nm λex / nm λem / nm 
τ1 / ns 
(λem / nm) 
τ2 / ns 
(λem / nm) 
W, OPEN 
(pH 3) 
305 320 358 
< 0.1 
 
 
W, CYCLIC 
(pH 3) 
282 280 358 
 < 0.2 
 
 
W¯ 
(pH 9) 
308 320 390 
 < 0.2 
 
 
W-Me-β-CD, 
OPEN 
(pH 3) 
306 320a 358 
< 0.1 
(358) 
2.0±0.4b 
(375) 
W¯-Me-β-CD 
(pH 9) 
309 320 390 
< 0.2 
(390) 
1.22±0.02b 
(390) 
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Figure 28:Emission decays collected at 370 nm for W at 25 µM in absence and in 
presence of Me-β-CD (1.0 mM) upon exciting at 320 nm. IRF is the instrument response 
function of ~ 90 ps 
Figure 29: Emission decays collected at 370 nm for W at 25 µM in absence and in 
presence of Me-β-CD (1.0 mM) upon exciting at 280 nm. No change in fluorescence 
lifetime upon excitation at 280 nm. IRF is the instrument response function of ~ 90 
ps 
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Accordingly, the corresponding DAS spectra in Figures 30-31 (see 
experimental section) are thus best interpreted by assuming contribution from both 
free and CD-complexed drug. The emission of free drug at pH 3 dominates the 
emission spectrum with emission band centered at 358 nm (Figure 30). The 
corresponding complex at this pH has an emission peak at ~ 375 nm with a longer 
excited-state lifetime ~ 2.0 ns, yet a much lower emission quantum yield (0.006 vs. 
0.0005 in Table 3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure..30: Decay-associated spectra (DAS) of two-component mixture of 
flurophores for W-Me-β-CD host-guest complex (25 μM for W and 1 mM for W-
Me-β-CD) at pH 3 upon exciting at 320 nm at room temperature. The corresponding 
steady-state spectra of each solution are also shown for comparison (see 
experimental section) 
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Separation of the two lifetimes by DAS method enables us to calculate 
radiative (kr) and non-radiative rate constants (knr) alongside emission quantum yield 
(ФF) upon complexation of W to Me-β-CD, as illustrated in Table 3.  
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Figure..31: Decay-associated spectra (DAS) of two-component mixture of 
flurophores for W-Me-β-CD host-guest complex (25 μM for W and 1 mM for W-
Me-β-CD) at pH 10 and upon exciting at 320 nm at room temperature. The 
corresponding steady-state spectra of each solution are also shown for comparison 
(see experimental section) 
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Table 3:  Fluorescence quantum yield ФF, Radiative rate constant kr, and Non-
radiative rate constant knr 
 
 
aMeasured using warfarin (W) in phosphate-buffered saline (PBS, pH ~7.4, 10 mM sodium 
phosphate) as the standard (ФF  = 0.012) [46], and calculated using the known equation [55] :         
∅𝑢𝑛𝑘 = ∅𝑠𝑡𝑑 (
𝐼𝑢𝑛𝑘
𝐴𝑢𝑛𝑘
) (
𝐴𝑠𝑡𝑑
𝐼𝑠𝑡𝑑
) (
𝑛𝑢𝑛𝑘
𝑛𝑠𝑡𝑑
)
2
, where n is the refractive indices for the standard (std) 
and experimental (unk) solvents, I is the fluorescence integral of the emission between 300 
and 550 nm, and A is the absorbance at the excitation wavelength. b Calculated using the 
known equations: ∅ =
kr
kr+knr
 , τ = 1
kr+knr
, knr =
1−∅
τ
, and kr =
∅
τ
 . 
 
The variations of kr values in the absence and presence of CD are difficult to 
explain because of the unreliable measurement of lifetimes in water. However, the 
red shifts of emission peaks of W upon complexation to Me-β-CD hosts at pH 3 
despite their non-polar hydrophobic and rigid cavity along with concomitant 
significant decrease of the kr values by ~2 orders of magnitude, from kr = ~6 ×10
7 to 
2 × 105 s-1, means that the enhancement in excited-state lifetimes is best described by 
a radiative-rate law [55].  
This argument is supported by the boarder UV-visible spectrum of W when 
compared to that spectrum in water upon inclusion to CD, as shown in Figure 14 and 
in light of Strickler-Berg equation [55].  Karlsson et al. [45] pointed out the 
possibility of attributing the longer lifetime of W observed in ethanol (0.45 ns, λex = 
295 nm) to the formation of solute-solvent hydrogen-bonded complexes. 
Drug Forms 
 
λex / nm ФF  (× 10-3)a kr (× 107 s-1)b knr (× 109 s-1)b 
τ / ns 
(Mean) 
W 
OPEN 
320  6 ± 0.01 > 6   > 10 < 0.1  
W¯ 320 12 ± 0.01 > 12  > 10 < 0.1 
Me-β-CD 
OPEN 
320  0.5 ± 0.01  0.02  0.50 2.0 
W¯-Me-β-CD 320 24 ± 0.01 2.0 0.81 1.22 
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 Dondon et al. [56] also posited that for other 4-hydroxycoumarin derivatives 
similar hydrogen-bonded complexes could have formed between the coumarin 
lactone group and the CD secondary hydroxyl groups. It transpires that there is a 
plausible explanation to the fluorescence behaviors of protonated W-CD systems that 
similar hydrogen-bonded complexes have formed between CD secondary hydroxyl 
group and the carbonyl group of open form, which the cyclic form lacks. 
 It is worth to mention that the low binding affinity of our W-CD system in 
the present study limits its potential use for biomedical applications as a large 
fraction of free guest will always persist at any concentration of the added host. 
However, understanding the factors that enhance the binding constants of W 
with CDs such as the formation of hydrogen bonded complexes [45], [56] and the 
presence of methyl groups [49] alongside the investigation of pH effects on the 
complex stability should preclude further studies in the future on W-CD systems for 
the establishment of pH-driven stimuli-responsive systems. 
Emission decays collected at pH 9 Figure 36 and 37 (Appendix) gave DAS 
spectra (Figure 31) that demonstrated opposite effects induced by CD addition. In 
agreement with previous reports [46], [51], [57], the complex at pH 9 excited at 320 
nm has a higher emission yields than that of free drug with excited-state lifetime of  
1.22 ns and no change in peak position at ~ 390 nm (Table 3). Vasquez et al., 
suggested encapsulation of deprtonated W forms considerably suppresses the 
vibronic modes that provide pathways for non-radiative transitions between the 
excited and ground states of W, causing a decrease in the rates of the non-radiative 
decay processes.  
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Indeed, calculation supports these findings and the operation of energy-gap 
law in which the excited state S1 is more polar than the ground state S0. 
Consequently, S1 state will be much more destabilized in a nonpolar medium than 
the S0 state. Such an increase in energy gap results in a decrease in knr [58]. 
 While non-radiate rate constants in Table 3 decreases ~ 12 times upon 
inclusion in the hydrophobic interior of Me-β-CD, radiative rate constants decreases 
only ~ 6 times. The increase in lifetimes and associated decrease in knr of other 4-
hydroxycoumarin derivatives [56] from below 0.5 ns to 1.1–1.3 ns (depending on the 
derivative) was also observed upon sequestration of dyes into β-CD macromolecules. 
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Chapter 4: Conclusion 
 
In this work, time-resolved fluorescence spectra measured using picoseconds 
laser diode at 280 nm and 320 nm with selective exciting of isomers of W were 
conducted utilizing both global and target analysis to give more specific information 
about nature and dynamics of excited-states of warfarin in water and inside 
cyclodextrins. An increase in excited-sate lifetime of warfarin was observed upon its 
interaction with Me-β-CD with selective interactions towards the open form. The 
increase in lifetime of open form was explained by radiative rate law, while that of 
deprotonated form by energy-gap law. Lower acidity of the open form have been 
demonstrated. 
 Fluorescence properties of W inside cyclodextrins in aqueous solutions have 
attracted attentions in several occasions due to their implications in bioanalytical 
quantification of W in commercial pesticides [50], [59]–[61] or biological liquids 
[62] and in utilizing W as fluorescent probes or site marker to study drug-protein 
interactions [63], [64]. 
In addition to fluorescence properties better understanding of the interactions 
of W with cyclodextrin in ground-state should lead to better control on modulating 
its pKa values in solution [38], [49],
 with implications in analytical separation of drug 
by electrophoresis [53] liquid chromatography [65], [66], as well as its formulations 
[67] or clinical studies [68].  
In summary, these results give the structures present in cyclodextrin 
environment in ground-state and explain their kinetic behaviors in excited-state using 
quantitative time-resolved fluorescence tools, collectively leading to better 
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understanding on the role of cyclodextrin on manipulating the function of this 
anticoagulant drug in ground and excited states.  
4.1 Recommendations 
The following recommendations are suggested as possible ways to extend 
this study: 
1-Study the host-guest interactions of W with different macromolecules such 
as cucurbit[n]uril and other different cyclodextrins. 
2-Warfarin was selected because it is commercially used as drug that favors 
blood bleeding, while finding a stimuli (chemical competitor) that tune the form 
(open and cyclic) could control blood clotting/bleeding balance in the future.  
3- Study the photochemistry of other drugs and the encapsulation of these 
drugs with different macromolecules. 
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Appendix  
 
 
 
 
 
Figure 32: Collected emission decays measured over the emission spectrum of W at 
pH 3, excited at 320 nm from 330 to 490 nm every 10 nm with a dwell time of 50 s 
at each wavelength. Data at each wavelength were fitted to a mono-exponential 
model convoluted with IRF ~ 90 ps (as shown in the residuals) 
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Figure 33: Collected emission decays measured over the emission spectrum of W at 
pH 3, excited at 280 nm from 310 to 510 nm every 20 nm with a dwell time of 50 s 
at each wavelength. Data at each wavelength were fitted to a mono-exponential 
model convoluted with IRF ~90 ps (as shown in the residuals) 
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Figure 34: Collected emission decays measured over the emission spectrum of W-
Me-β-CD at pH 3, excited at 320 nm (Figure30) from 330 to 480 nm every 10 nm 
with a dwell time of 50 s at each wavelength. Data at each wavelength were fitted to 
a bi-exponential model convoluted with IRF ~ 90 ps (as shown in the residuals) 
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Figure 35: Collected emission decays measured over the emission spectrum of W-
Me-β-CD at pH 3, excited at 280 nm from 310 to 510 nm every 20 nm with a dwell 
time of 50 s at each wavelength. Data at each wavelength were fitted to a mono-
exponential model convoluted with IRF ~ 90 ps (as shown in the residuals) 
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Figure 36: Collected emission decays measured over the emission spectrum of W at 
pH 9, excited at 320 nm from 330 to 550 nm every 10 nm with a dwell time of 50 s 
at each wavelength Data at each wavelength were fitted to a mono-exponential 
model convoluted with IRF ~ 90 ps (as shown in the residuals) 
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Figure 37: Collected emission decays measured over the emission spectrum of W-
Me-β-CD at pH 9, excited at 320 nm (Figure 31) from 330 to 550 nm every 5 nm 
with a dwell time of 50 s at each wavelength. Data at each wavelength were fitted to 
a bi-exponential model convoluted with IRF~ 90 ps (as shown in the residuals) 
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